📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma. (2021)

First Author: Couillard S

Attributed to: United Kingdom Refractory Asthma Stratification Programme (RASP-UK) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1164/rccm.202104-1040le

PubMed Identifier: 34129808

Publication URI: http://europepmc.org/abstract/MED/34129808

Type: Journal Article/Review

Volume: 204

Parent Publication: American journal of respiratory and critical care medicine

Issue: 6

ISSN: 1073-449X